Investigating the Use of a Liquid Immunogenic Fiducial Eluter Biomaterial in Cervical Cancer Treatment

M Moreau, LS Keno, D China, S Mao, S Acter, G Sy… - Cancers, 2024 - mdpi.com
Simple Summary Current treatment options for advanced cervical cancer are limited, with a
5-year overall survival rate of 17%. New effective therapeutic approaches that can increase …